Capivasertib for endometrial neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 22 Oct 2010: Trial registered, NCT01226316
  2. 1 Dec 2010: Trial started, NCT01226316

The trials

NCT01226316: Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

State
Completed
Phase
Phase 1
People
285 taking part
Started
1 Dec 2010
Primary completion
26 Apr 2019
Arms
Part A and B Schedule 1, Continuous dosing, Parts A,B,C,D Schedule 2, Intermittent dosing, Parts A and B Schedule 3, Intermittent dosing., Parts E and F, Intermittent dosing with Fulvestrant
Results
None posted
  1. 22 Oct 2010: Trial registered
  2. 1 Dec 2010: Trial started
  3. 3 Dec 2024: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

About the treatment

Kind of treatment: Drug.

Also known as Truqap.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.